This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory product recall

Nara Organics Recalls Infant Formula

Analysis based on 44 articles · First reported Jun 13, 2026 · Last updated Jun 15, 2026

Sentiment
-70
Attention
6
Articles
44
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The recall of Nara Organics infant formula due to botulism concerns will negatively impact the company's stock price and reputation. Retailers like Oracle Corporation may also experience a slight negative impact due to their association with the recalled product, though the overall market impact is limited as Nara Organics represents a small fraction of the infant formula market.

food manufacturing retail

Nara Organics has voluntarily recalled all lots of its Whole Milk Organic Powdered Infant Formula sold nationwide in Target stores and online after three infants in United States — California, United States — Pennsylvania, and Washington were diagnosed with infant botulism. The infants, aged 2 to 5 months, became ill between April and May after consuming the formula and were successfully treated with Baby BIG. While no Nara formula has tested positive for Clostridium botulinum bacteria to date, the company initiated the recall out of an abundance of caution. The United States — Food and Drug Administration and the United States — Centers for Disease Control and Prevention are investigating the outbreak and have advised parents to immediately stop using the recalled formula. The recall is not expected to cause a nationwide formula shortage as Nara Organics accounts for less than 1% of the U.S. infant formula market.

priv
Nara Organics voluntarily recalled all its infant formula products due to a potential link to infant botulism cases, leading to significant financial and reputational damage. The company is offering refunds to affected customers.
Importance 100.0 Sentiment -90.0
govactor
The United States — Centers for Disease Control and Prevention confirmed the link between Nara Organics formula and infant botulism cases, providing guidance to parents and assisting in the investigation.
Importance 80.0 Sentiment 0.0
govactor
The United States — Food and Drug Administration announced the recall of Nara Organics infant formula and is investigating the multistate botulism outbreak, ensuring public safety and regulatory compliance.
Importance 80.0 Sentiment 0.0
stock
Oracle Corporation is a major retailer that sold the recalled Nara Organics infant formula. It is involved in the recall process by accepting returns and facilitating refunds for customers.
Importance 70.0 Sentiment -20.0
loc
United States — Washington (state) is one of the states where infants became ill after consuming Nara Organics formula, demonstrating the widespread impact of the contaminated product.
Importance 40.0 Sentiment 0.0
loc
United States — California is one of the states where infants became ill after consuming Nara Organics formula, highlighting the geographical spread of the botulism outbreak.
Importance 40.0 Sentiment 0.0
loc
United States — Pennsylvania is one of the states where infants became ill after consuming Nara Organics formula, indicating the multistate nature of the botulism outbreak.
Importance 40.0 Sentiment 0.0
oth
Baby BIG is the FDA-approved treatment for infant botulism, and the affected infants were treated with this medication, underscoring its critical role in managing the illness.
Importance 30.0 Sentiment 20.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.